MedTrace Logo

Hyaluronic Acid in Shoulder Tendinopathy

NCT06376981 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2024-10-03

No results posted yet for this study

Summary

Multicentric, randomised study to compare the effectiveness on activity pain at 3 months of corticosteroid injection associated with hyaluronic acid with corticosteroids injection alone in patients with tendinopathy of the supraspinatus with clinical reevaluation at one, three and six months.

Conditions

  • Shoulder Tendinitis

Interventions

DRUG

Hyaluronic acid injection

An injection of 2 ml of Acid hyaluronic

DRUG

Corticosteroid injection

An injection of 1 ml of corticosteroids

DRUG

Placebo injection

An injection of 2 ml of placebo (physiological serum)

Sponsors & Collaborators

  • Centre Hospitalier Departemental Vendee

    lead OTHER

Principal Investigators

  • Céline COZIC, Dr · Centre Hospitalier Départemental Vendée

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-19
Primary Completion
2026-12-19
Completion
2027-03-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06376981 on ClinicalTrials.gov